TrialEuropean journal of clinical pharmacology2024

DAHOS Study: Efficacy of dapagliflozin in treating heart failure with reduced ejection fraction and obstructive sleep apnea syndrome - A 3-month, multicenter, randomized controlled clinical trial.

Liang Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.